135 related articles for article (PubMed ID: 35732410)
1. CD19 immunostaining of a stored paraffin-embedded vitrectomy cell block of intraocular lymphoma contributing to chimera antigen receptor T-cell therapy.
Matsuo T; Tanaka T; Fujii N; Fujii K; Kondo E
J Clin Exp Hematop; 2022 Sep; 62(3):187-189. PubMed ID: 35732410
[No Abstract] [Full Text] [Related]
2. PRESUMPTIVE RECURRENCE OF INTRAOCULAR LYMPHOMA DESPITE CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY.
Taher A; Abadir E; McCluskey P; Hamad N; Lo TH; Heydon P
Retin Cases Brief Rep; 2023 Sep; 17(5):562-566. PubMed ID: 37643043
[TBL] [Abstract][Full Text] [Related]
3. Intraocular lymphoma: diagnostic approach and immunophenotypic findings in vitrectomy specimens.
Raparia K; Chang CC; Chévez-Barrios P
Arch Pathol Lab Med; 2009 Aug; 133(8):1233-7. PubMed ID: 19653716
[TBL] [Abstract][Full Text] [Related]
4. Two types of initial ocular manifestations in intraocular-central nervous system lymphoma.
Matsuo T; Yamaoka A; Shiraga F; Matsuo N
Retina; 1998; 18(4):301-7. PubMed ID: 9730171
[TBL] [Abstract][Full Text] [Related]
5. Are there primary intraocular lymphomas that do not develop into central nervous system lymphomas?
Matsuo T; Tanaka T
J Clin Exp Hematop; 2019 Dec; 59(4):168-174. PubMed ID: 31611509
[TBL] [Abstract][Full Text] [Related]
6. Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma.
Akpek EK; Maca SM; Christen WG; Foster CS
Ophthalmology; 1999 Dec; 106(12):2291-5. PubMed ID: 10599659
[TBL] [Abstract][Full Text] [Related]
7. Pathologically Proven Intraocular Infiltration With Adult T-Cell Leukemia/Lymphoma: Two New Cases With Either Vitreous Opacity or Aqueous Hypopyon and Literature Review of 16 Cases.
Matsuo T; Shimizu T; Tanaka T; Yamamoto A; Takasuka H
J Investig Med High Impact Case Rep; 2020; 8():2324709620966843. PubMed ID: 33078639
[TBL] [Abstract][Full Text] [Related]
8. [Malignant non-Hodgkin lymphoma of the central nervous system with ocular site. Value of vitrectomy for diagnosis].
Maalouf T; Angioi-Duprez K; Guibaud I; Baty V; May T; Plenat F; Canton P; George JL
J Fr Ophtalmol; 1997; 20(9):693-6. PubMed ID: 9587581
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography/computed tomography after immunocytochemical and clonal diagnosis of intraocular lymphoma with vitrectomy cell blocks.
Matsuo T; Ichimura K; Ichikawa T; Okumura Y; Kaji M; Yoshino T
J Clin Exp Hematop; 2009 Nov; 49(2):77-87. PubMed ID: 19907112
[TBL] [Abstract][Full Text] [Related]
10. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
11. Use of the polymerase chain reaction to detect B- and T-cell gene rearrangements in vitreous specimens from patients with intraocular lymphoma.
White VA; Gascoyne RD; Paton KE
Arch Ophthalmol; 1999 Jun; 117(6):761-5. PubMed ID: 10369586
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical diagnosis as inflammation by vitrectomy cell blocks in patients with vitreous opacity.
Matsuo T; Ichimura K
Ophthalmology; 2012 Apr; 119(4):827-37. PubMed ID: 22281090
[TBL] [Abstract][Full Text] [Related]
13. Cytopathological analysis of vitreous in intraocular lymphoma.
Intzedy L; Teoh SC; Hogan A; Mangwana S; Mayer EJ; Dick AD; Pawade J
Eye (Lond); 2008 Feb; 22(2):289-93. PubMed ID: 17767143
[TBL] [Abstract][Full Text] [Related]
14. Acquired immunodeficiency syndrome-related primary intraocular lymphoma.
Stanton CA; Sloan B; Slusher MM; Greven CM
Arch Ophthalmol; 1992 Nov; 110(11):1614-7. PubMed ID: 1332665
[TBL] [Abstract][Full Text] [Related]
15. Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome.
Chaput F; Amer R; Baglivo E; Touitou V; Kozyreff A; Bron D; Bodaghi B; LeHoang P; Bergstrom C; Grossniklaus HE; Chan CC; Pe'er J; Caspers LE
Ocul Immunol Inflamm; 2017 Oct; 25(5):639-648. PubMed ID: 27002464
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, With Bilateral Intraocular Involvement and Infiltration to the CNS.
Rozati S; Kempf W; Ostheeren-Michaelis S; Bode-Lesniewska B; Zimmermann DR; Dummer R; Cozzio A
J Clin Oncol; 2016 Apr; 34(11):e93-6. PubMed ID: 25267751
[No Abstract] [Full Text] [Related]
17. Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma.
Hill BT; Roberts ZJ; Xue A; Rossi JM; Smith MR
Bone Marrow Transplant; 2020 Jun; 55(6):1184-1187. PubMed ID: 31471571
[No Abstract] [Full Text] [Related]
18. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
[TBL] [Abstract][Full Text] [Related]
19. Intraocular Lymphoma.
Cunningham ET; Miserocchi E; Smith JR; Gonzales JA; Zierhut M
Ocul Immunol Inflamm; 2021 Apr; 29(3):425-429. PubMed ID: 34296968
[No Abstract] [Full Text] [Related]
20. Clinical development of anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.
Makita S; Yoshimura K; Tobinai K
Cancer Sci; 2017 Jun; 108(6):1109-1118. PubMed ID: 28301076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
